Dermatophytosis medical therapy: Difference between revisions

	Dermatophytosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Dermatophytosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiographic Findings
X-Ray Findings
CT scan Findings
MRI Findings
Ultrasound Findings
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Dermatophytosis medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Dermatophytosis medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA onDermatophytosis medical therapy
CDC on Dermatophytosis medical therapy
Dermatophytosis medical therapy in the news
Blogs on Dermatophytosis medical therapy
Directions to Hospitals Treating Dermatophytosis here
Risk calculators and risk factors for Dermatophytosis medical therapy

Revision as of 13:46, 23 May 2013

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Topical agents: antifungal topical agents such as miconazole, terbinafine, clotrimazole, ketoconazole, or tolnaftate applied twice daily until symptoms resolve (usually within one or two weeks). Topical treatments should then be continued for a further 7 days after resolution of visible symptoms to prevent recurrence. The total duration of treatment is therefore generally two weeks, but may be as long as three.

Oral Medications: in more severe cases or where there is scalp ringworm, systemic treatment with oral medications may be given.

To prevent spreading the infection, lesions should not be touched, and good hygiene maintained with washing of hands and the body.

@@ Line 5: / Line 5: @@
 {{CMG}}
 ==Medical Therapy==
-*Topical Agents: Antifungal topical agents such as [[miconazole]], [[terbinafine]], [[clotrimazole]], [[ketoconazole]], or [[tolnaftate]] applied twice daily until symptoms resolve (usually within one or two weeks). Topical treatments should then be continued for a further 7 days after resolution of visible symptoms to prevent recurrence. The total duration of treatment is therefore generally two weeks, but may be as long as three.
+*Topical agents: antifungal topical agents such as [[miconazole]], [[terbinafine]], [[clotrimazole]], [[ketoconazole]], or [[tolnaftate]] applied twice daily until symptoms resolve (usually within one or two weeks). Topical treatments should then be continued for a further 7 days after resolution of visible symptoms to prevent recurrence. The total duration of treatment is therefore generally two weeks, but may be as long as three.
-*Oral Medications: In more severe cases or where there is scalp ringworm, systemic treatment with oral medications may be given.
+*Oral Medications: in more severe cases or where there is scalp ringworm, systemic treatment with oral medications may be given.
 *To prevent spreading the [[infection]], [[lesion]]s should not be touched, and good hygiene maintained with washing of hands and the body.
-*Infected pets also should be treated.
+*Infected pets should also be treated.
 ==References==